Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies

Springer Semin Immunopathol. 1998;20(1-2):73-94. doi: 10.1007/BF00832000.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • Antibody Specificity
  • Arthritis, Rheumatoid / etiology
  • Arthritis, Rheumatoid / pathology*
  • Arthritis, Rheumatoid / therapy
  • Biological Factors / physiology
  • Biopsy
  • Bursa, Synovial / cytology
  • Bursa, Synovial / immunology
  • Chemokines / analysis
  • Chemokines / pharmacology
  • Fibroblasts / chemistry
  • Fibroblasts / drug effects
  • Fluorescent Antibody Technique, Indirect
  • Growth Substances / physiology
  • Humans
  • Neovascularization, Pathologic / physiopathology*
  • Neovascularization, Pathologic / therapy
  • Platelet Endothelial Cell Adhesion Molecule-1 / immunology
  • Receptors, Vitronectin / immunology
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Biological Factors
  • Chemokines
  • Growth Substances
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Receptors, Vitronectin